Yang Wei-Na, Ma Kai-Ge, Qian Yi-Hua, Zhang Jian-Shui, Feng Gai-Feng, Shi Li-Li, Zhang Zhi-Chao, Liu Zhao-Hui
Department of Human Anatomy, Histology and Embryology, Institute of Neurobiology, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an 710061, China.
Department of Human Anatomy, Histology and Embryology, Institute of Neurobiology, Key Laboratory of Environment and Genes Related to Diseases of Education Ministry, Xi'an Jiaotong University Health Science Center, 76 Yanta West Road, Xi'an 710061, China.
Int J Biochem Cell Biol. 2015 Jul;64:252-64. doi: 10.1016/j.biocel.2015.04.013. Epub 2015 Apr 29.
Mounting evidence suggests that the pathological hallmarks of Alzheimer's disease (AD) are caused by the intraneuronal accumulation of beta-amyloid protein (Aβ). Reuptake of extracellular Aβ is believed to contribute significantly to the intraneuronal Aβ pool in the early stages of AD. Published reports have claimed that the low-density lipoprotein receptor-related protein 1 (LRP1) mediates Aβ1-42 uptake and lysosomal trafficking in GT1-7 neuronal cells and mouse embryonic fibroblast non-neuronal cells. However, there is no direct evidence supporting the role of LRP1 in Aβ internalization in primary neurons. Our recent study indicated that p38 MAPK and ERK1/2 signaling pathways are involved in regulating α7 nicotinic acetylcholine receptor (α7nAChR)-mediated Aβ1-42 uptake in SH-SY5Y cells. This study was designed to explore the regulation of MAPK signaling pathways on LRP1-mediated Aβ internalization in neurons. We found that extracellular Aβ1-42 oligomers could be internalized into endosomes/lysosomes and mitochondria in cortical neurons. Aβ1-42 and LRP1 were also found co-localized in neurons during Aβ1-42 internalization, and they could form Aβ1-42-LRP1 complex. Knockdown of LRP1 expression significantly decreased neuronal Aβ1-42 internalization. Finally, we identified that p38 MAPK and ERK1/2 signaling pathways regulated the internalization of Aβ1-42 via LRP1. Therefore, these results demonstrated that LRP1, p38 MAPK and ERK1/2 mediated the internalization of Aβ1-42 in neurons and provided evidence that blockade of LRP1 or inhibitions of MAPK signaling pathways might be a potential approach to lowering brain Aβ levels and served a potential therapeutic target for AD.
越来越多的证据表明,阿尔茨海默病(AD)的病理特征是由β-淀粉样蛋白(Aβ)在神经元内的积累引起的。据信,细胞外Aβ的再摄取在AD早期对神经元内Aβ池有显著贡献。已发表的报告称,低密度脂蛋白受体相关蛋白1(LRP1)介导GT1-7神经元细胞和小鼠胚胎成纤维细胞(非神经元细胞)对Aβ1-42的摄取和溶酶体运输。然而,没有直接证据支持LRP1在原代神经元Aβ内化中的作用。我们最近的研究表明,p38丝裂原活化蛋白激酶(MAPK)和细胞外信号调节激酶1/2(ERK1/2)信号通路参与调节SH-SY5Y细胞中α7烟碱型乙酰胆碱受体(α7nAChR)介导的Aβ1-42摄取。本研究旨在探讨MAPK信号通路对神经元中LRP1介导的Aβ内化的调节作用。我们发现,细胞外Aβ1-42寡聚体可被内化到皮质神经元的内体/溶酶体和线粒体中。在Aβ1-42内化过程中,还发现Aβ1-42和LRP1在神经元中共定位,并且它们可以形成Aβ1-42-LRP1复合物。敲低LRP1表达显著降低神经元对Aβ1-42的内化。最后,我们确定p38 MAPK和ERK1/2信号通路通过LRP1调节Aβ1-42的内化。因此,这些结果表明,LRP1、p38 MAPK和ERK1/2介导神经元中Aβ1-42的内化,并提供证据表明阻断LRP1或抑制MAPK信号通路可能是降低脑内Aβ水平的潜在方法,并且是AD的潜在治疗靶点。